Two global powerhouse organizations with a united mission to find a solution to and help people with blood cancer have reinforced their partnership to give a nationwide boost to the Light the Night series of fundraising events, happening all over the country. The Sarah Cannon Blood Cancer Network, one of the largest providers of blood cancer care including blood and marrow transplantation (BMT) across the United States and United Kingdom, is driving a great amount of support towards The Leukemia & Lymphoma Society (LLS), the world’s largest voluntary health agency dedicated to blood cancer.
This is Sarah Cannon’s second year to sign with the LLS as a national sponsor, bolstering its support this Fall for the Light the Night campaign, which by itself has helped raise over $1 billion worth of funds for groundbreaking research. The Sarah Cannon Cancer Network is prepared to locally and directly support LLS activities, especially in areas where it runs its own facilities, such as in Nashville, TN; Denver, CO; Texas cities San Antonio, Austin, Frisco and Dallas; Kansas City, MO; Las Vegas, NV; Oklahoma City and Tulsa, OK; Richmond, VA; Salt Lake City, UTand New Orleans, LA.
Sarah Cannon CEO Dee Anna Smith is running on her third year as a member of the LLS’ Executive Committee at the Tennessee Chapter, and her second year as Light The Night Corporate Walk chair. “At Sarah Cannon, we are committed to advancing therapies for blood cancer patients by delivering the highest quality care through the integration of training, research, patient navigation, and cutting-edge technology,” said Smith. “We are proud to stand with LLS to promote progress in research and to elevate patient care standards with the collective mission to build a world free of blood cancer.”
LLS’s president and CEO Dr. Louis J. DeGennaro, said, “The Sarah Cannon Blood Cancer Network and LLS are a perfect fit given our mutual focus on touching patients directly with care and support services, facilitating enrollment in clinical trials, and advancing research from bench to bedside to develop new, lifesaving therapies. Sarah Cannon’s support of Light The Night Walk will bring much needed awareness to blood cancers and the need to invest in cures and ensure patients have access to treatments.”
